Equity Profile

FIGS

FIGS, Inc.

Consumer DiscretionaryApparel, Accessories & Luxury Goods$2.0B

May7Thu

Post-Earnings Recap

ReportedQ1-2026After Close4:05 PM EDT

FIGS, Inc. Beats on EPS, Stock Up 6.0%

Metric	Actual	Expected	Surprise
EPS	$0.03	$0.02	+130.77%
Revenue	—	$153M	—

management commentary, guidance changes, and full analysis available with Pro.

FIGS, Inc. Beats on EPS, Stock Up 6.0%

Key Numbers

Metric	Actual	Expected	Surprise
EPS	$0.03	$0.02	+130.77%
Revenue	—	$153M	—

Management Commentary

Tone: Unknown

No transcript is on record, and the analysis is based on numerical results only.

What It Means

FIGS, Inc. reported better-than-expected earnings per share, which likely contributed to a 6% increase in the stock price. However, there was no revenue reported, making it difficult to assess overall performance. Investors may be encouraged by the EPS beat, but the lack of revenue data leaves some uncertainty.

Company Snapshot

FIGS, Inc. is a consumer discretionary company specializing in high-quality medical scrubs and apparel....

Key Metrics to Watch

EPS

Earnings per share is a key indicator of profitability and investor sentiment.

$0.02

Revenue

Revenue growth reflects the company's ability to attract and retain customers in a competitive market.

$153M

Wall Street expectations, options signals, track record, and call prep available with Pro.

Original Pre-Earnings Preview

Context

Company Snapshot

FIGS, Inc. is a consumer discretionary company specializing in high-quality medical scrubs and apparel. With a market cap of $2 billion, FIGS is positioned in the apparel and accessories industry, catering to healthcare professionals who seek stylish and functional workwear.

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

88%

Avg EPS Surprise

+140.61%

Avg Stock Reaction

+3.75%

Last Quarter Recap

In Q4 2025, FIGS reported an EPS of $0.10, significantly exceeding expectations, which led to a positive market reaction with a 13.78% stock increase the following day. The company has consistently surprised analysts with better-than-expected earnings in recent quarters.

Management Promises & Guidance

Expectations

Wall Street Expectations

Analysts expect FIGS to report modest earnings growth this quarter, with a consensus EPS of $0.02 and revenue of $153 million. The stock's recent performance suggests that investors are cautiously optimistic.

Bull Case

If FIGS beats earnings expectations again, it could signal strong demand for its products and lead to a positive reassessment of its growth potential.

Bear Case

Conversely, if FIGS fails to meet expectations, it may raise concerns about its market position and growth trajectory, potentially leading to a sell-off.

Key Metrics to Watch

EPS

$0.02

Earnings per share is a key indicator of profitability and investor sentiment.

Revenue

$153M

Revenue growth reflects the company's ability to attract and retain customers in a competitive market.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will FIGS achieve an EPS of $0.02 or higher this quarter?

This EPS figure is critical as it will indicate whether the company can maintain its recent trend of exceeding earnings expectations.

What are the revenue figures for this quarter compared to the consensus of $153 million?

Revenue performance will provide insights into consumer demand and the company's market position, which are crucial for future growth.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may underestimate FIGS' ability to capitalize on rising healthcare spending and the ongoing trend of upgrading medical apparel.

Supporting Evidence

FIGS has consistently beaten EPS estimates, indicating stronger operational performance than anticipated.

The options market is pricing a larger move than historical averages, suggesting that traders expect significant news.

Recent consumer trends show increased spending in healthcare, which could benefit FIGS more than analysts expect.

Key Risk

If revenue comes in below $151 million, it could challenge the optimistic outlook for FIGS' growth.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The market is debating whether FIGS can sustain its growth momentum amidst increasing competition in the apparel sector.

Bull Confirmed If

An EPS of $0.02 or better with revenue exceeding $153 million would confirm the bull case.

Bear Confirmed If

An EPS below $0.01 or revenue significantly under $151 million would confirm the bear case.

Pre-Earnings Positioning

Options Market

Implied Move

±19.96%

Historical Avg

±4.5%

Pricing rich

The options market is pricing in a significant move, indicating that traders expect volatility around the earnings announcement.

Options are pricing ±32.1% while FIGS has averaged ±4.5% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

2.3%

30d HV

64.7%

Calls (42K)P/C Ratio: 0.25Puts (10K)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If FIGS beats expectations, history suggests the stock could rise by an average of 4.24%, confirming strong demand and growth potential.

In-Line / Cautious

If results are in line with expectations, the stock may experience a muted reaction as investors await further guidance.

Miss

A miss could lead to a decline, with historical patterns suggesting an average drop of around 4.24%.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches or collaborations that could drive sales.
2Insights into customer acquisition strategies and retention rates.
3Management's commentary on market trends and competitive landscape.
4Details on supply chain management and cost control measures.
5Any guidance on future earnings expectations or strategic initiatives.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

May4

BMRNReported

BioMarin Pharmaceutical Inc.

RecapView

May4

PLTRReported

Company Snapshot

FIGS, Inc. is a consumer discretionary company specializing in high-quality medical scrubs and apparel....

Key Metrics to Watch

EPS

Earnings per share is a key indicator of profitability and investor sentiment.

$0.02

Revenue

Revenue growth reflects the company's ability to attract and retain customers in a competitive market.

$153M

Wall Street expectations, options signals, track record, and call prep available with Pro.

Original Pre-Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

88%

Avg EPS Surprise

+140.61%

Avg Stock Reaction

+3.75%

Last Quarter Recap

Management Promises & Guidance

Expectations

Wall Street Expectations

Bull Case

If FIGS beats earnings expectations again, it could signal strong demand for its products and lead to a positive reassessment of its growth potential.

Bear Case

Conversely, if FIGS fails to meet expectations, it may raise concerns about its market position and growth trajectory, potentially leading to a sell-off.

Key Metrics to Watch

EPS

$0.02

Earnings per share is a key indicator of profitability and investor sentiment.

Revenue

$153M

Revenue growth reflects the company's ability to attract and retain customers in a competitive market.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will FIGS achieve an EPS of $0.02 or higher this quarter?

This EPS figure is critical as it will indicate whether the company can maintain its recent trend of exceeding earnings expectations.

What are the revenue figures for this quarter compared to the consensus of $153 million?

Revenue performance will provide insights into consumer demand and the company's market position, which are crucial for future growth.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may underestimate FIGS' ability to capitalize on rising healthcare spending and the ongoing trend of upgrading medical apparel.

Supporting Evidence

FIGS has consistently beaten EPS estimates, indicating stronger operational performance than anticipated.

The options market is pricing a larger move than historical averages, suggesting that traders expect significant news.

Recent consumer trends show increased spending in healthcare, which could benefit FIGS more than analysts expect.

Key Risk

If revenue comes in below $151 million, it could challenge the optimistic outlook for FIGS' growth.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The market is debating whether FIGS can sustain its growth momentum amidst increasing competition in the apparel sector.

Bull Confirmed If

An EPS of $0.02 or better with revenue exceeding $153 million would confirm the bull case.

Bear Confirmed If

An EPS below $0.01 or revenue significantly under $151 million would confirm the bear case.

Pre-Earnings Positioning

Options Market

Implied Move

±19.96%

Historical Avg

±4.5%

Pricing rich

The options market is pricing in a significant move, indicating that traders expect volatility around the earnings announcement.

Options are pricing ±32.1% while FIGS has averaged ±4.5% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

2.3%

30d HV

64.7%

Calls (42K)P/C Ratio: 0.25Puts (10K)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If FIGS beats expectations, history suggests the stock could rise by an average of 4.24%, confirming strong demand and growth potential.

In-Line / Cautious

If results are in line with expectations, the stock may experience a muted reaction as investors await further guidance.

Miss

A miss could lead to a decline, with historical patterns suggesting an average drop of around 4.24%.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches or collaborations that could drive sales.
2Insights into customer acquisition strategies and retention rates.
3Management's commentary on market trends and competitive landscape.
4Details on supply chain management and cost control measures.
5Any guidance on future earnings expectations or strategic initiatives.